Drug target gene-based analyses of drug repositionability in rare and intractable diseases
Abstract Drug development for rare and intractable diseases has been challenging for decades due to the low prevalence and insufficient information on these diseases. Drug repositioning is increasingly being used as a promising option in drug development. We aimed to analyze the trend of drug reposi...
Enregistré dans:
Auteurs principaux: | Ryuichi Sakate, Tomonori Kimura |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/43ce3b52f56b4575b6624b17c048893f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Integrative network analyses of transcriptomics data reveal potential drug targets for acute radiation syndrome
par: Robert Moore, et autres
Publié: (2021) -
Mining the transcriptome for rare disease therapies: a comparison of the efficiencies of two data mining approaches and a targeted cell-based drug screen
par: A. J. Mears, et autres
Publié: (2017) -
Role of biologics in intractable urticaria
par: Cooke A, et autres
Publié: (2015) -
Choriocarcinoma in a viable pregnancy with the rare presentation of intractable lower back pain
par: Lulu Huang, et autres
Publié: (2021) -
Machine learning workflow to enhance predictions of Adverse Drug Reactions (ADRs) through drug-gene interactions: application to drugs for cutaneous diseases
par: Kalpana Raja, et autres
Publié: (2017)